Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03861988 · ClinicalTrials.gov registry record · Phase 4

Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery

A Phase 4 study, sponsored by Stanford University.

Completed
Registry status
Phase 4
Development phase
45
Enrollment target

NCT03861988: Completed Phase 4 study, sponsored by Stanford University.

NCT03861988 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03861988, a Phase 4 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 4
Development phase
45 participants
Enrollment target

Study Summary

This study evaluates whether ketamine, given as part of an anesthetic, improves depression symptoms in depressed patients undergoing non-cardiac surgery. Half of participants will receive a ketamine infusion during surgery, while the other half will receive a placebo (normal saline) during surgery.

Interventions

  • DRUG Ketamine
  • DRUG Normal saline (placebo)

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2019-08-22
Est. Completion 2022-09-27
Phase Phase 4

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03861988

The ClinicalTrials.gov registry entry for NCT03861988 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.

NCT03861988 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03861988 about?

NCT03861988 is a clinical study titled "Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery". This study evaluates whether ketamine, given as part of an anesthetic, improves depression symptoms in depressed patients undergoing non-cardiac surgery. Half of participants will receive a ketamine infusion during surgery, while the other half will receive a placebo (normal saline) during surgery.

What is the current status of trial NCT03861988?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2019-08-22. Estimated completion is 2022-09-27.

What interventions are being tested in trial NCT03861988?

The interventions under investigation include: Ketamine (DRUG), Normal saline (placebo) (DRUG).

Who is sponsoring clinical trial NCT03861988?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.